table of content
1 Introduction to Research & Analysis Reports
1.1 Plasmid DNA Manufacturing Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Plasmid DNA Manufacturing Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Plasmid DNA Manufacturing Services Overall Market Size
2.1 Global Plasmid DNA Manufacturing Services Market Size: 2021 VS 2028
2.2 Global Plasmid DNA Manufacturing Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Plasmid DNA Manufacturing Services Players in Global Market
3.2 Top Global Plasmid DNA Manufacturing Services Companies Ranked by Revenue
3.3 Global Plasmid DNA Manufacturing Services Revenue by Companies
3.4 Top 3 and Top 5 Plasmid DNA Manufacturing Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Plasmid DNA Manufacturing Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasmid DNA Manufacturing Services Players in Global Market
3.6.1 List of Global Tier 1 Plasmid DNA Manufacturing Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Plasmid DNA Manufacturing Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Plasmid DNA Manufacturing Services Market Size Markets, 2021 & 2028
4.1.2 Research-Grade Plasmids
4.1.3 High Quality (HQ) / GMP-Ready? Plasmids
4.1.4 CGMP Plasmid
4.1.5 Others
4.2 By Type - Global Plasmid DNA Manufacturing Services Revenue & Forecasts
4.2.1 By Type - Global Plasmid DNA Manufacturing Services Revenue, 2017-2022
4.2.2 By Type - Global Plasmid DNA Manufacturing Services Revenue, 2023-2028
4.2.3 By Type - Global Plasmid DNA Manufacturing Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Plasmid DNA Manufacturing Services Market Size, 2021 & 2028
5.1.2 Medical Industry
5.1.3 Biological Industry
5.1.4 Others
5.2 By Application - Global Plasmid DNA Manufacturing Services Revenue & Forecasts
5.2.1 By Application - Global Plasmid DNA Manufacturing Services Revenue, 2017-2022
5.2.2 By Application - Global Plasmid DNA Manufacturing Services Revenue, 2023-2028
5.2.3 By Application - Global Plasmid DNA Manufacturing Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Plasmid DNA Manufacturing Services Market Size, 2021 & 2028
6.2 By Region - Global Plasmid DNA Manufacturing Services Revenue & Forecasts
6.2.1 By Region - Global Plasmid DNA Manufacturing Services Revenue, 2017-2022
6.2.2 By Region - Global Plasmid DNA Manufacturing Services Revenue, 2023-2028
6.2.3 By Region - Global Plasmid DNA Manufacturing Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Plasmid DNA Manufacturing Services Revenue, 2017-2028
6.3.2 US Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.3.3 Canada Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.3.4 Mexico Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Plasmid DNA Manufacturing Services Revenue, 2017-2028
6.4.2 Germany Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.3 France Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.4 U.K. Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.5 Italy Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.6 Russia Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.7 Nordic Countries Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.4.8 Benelux Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Plasmid DNA Manufacturing Services Revenue, 2017-2028
6.5.2 China Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.5.3 Japan Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.5.4 South Korea Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.5.5 Southeast Asia Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.5.6 India Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Plasmid DNA Manufacturing Services Revenue, 2017-2028
6.6.2 Brazil Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.6.3 Argentina Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Plasmid DNA Manufacturing Services Revenue, 2017-2028
6.7.2 Turkey Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.7.3 Israel Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.7.4 Saudi Arabia Plasmid DNA Manufacturing Services Market Size, 2017-2028
6.7.5 UAE Plasmid DNA Manufacturing Services Market Size, 2017-2028
7 Players Profiles
7.1 Vigene Biosciences
7.1.1 Vigene Biosciences Corporate Summary
7.1.2 Vigene Biosciences Business Overview
7.1.3 Vigene Biosciences Plasmid DNA Manufacturing Services Major Product Offerings
7.1.4 Vigene Biosciences Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.1.5 Vigene Biosciences Key News
7.2 Aldevron
7.2.1 Aldevron Corporate Summary
7.2.2 Aldevron Business Overview
7.2.3 Aldevron Plasmid DNA Manufacturing Services Major Product Offerings
7.2.4 Aldevron Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.2.5 Aldevron Key News
7.3 Creative Biogene
7.3.1 Creative Biogene Corporate Summary
7.3.2 Creative Biogene Business Overview
7.3.3 Creative Biogene Plasmid DNA Manufacturing Services Major Product Offerings
7.3.4 Creative Biogene Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.3.5 Creative Biogene Key News
7.4 Thermo Fisher Scientific Inc.
7.4.1 Thermo Fisher Scientific Inc. Corporate Summary
7.4.2 Thermo Fisher Scientific Inc. Business Overview
7.4.3 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Major Product Offerings
7.4.4 Thermo Fisher Scientific Inc. Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Inc. Key News
7.5 Kaneka Eurogentec SA
7.5.1 Kaneka Eurogentec SA Corporate Summary
7.5.2 Kaneka Eurogentec SA Business Overview
7.5.3 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Major Product Offerings
7.5.4 Kaneka Eurogentec SA Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.5.5 Kaneka Eurogentec SA Key News
7.6 AGC Biologics
7.6.1 AGC Biologics Corporate Summary
7.6.2 AGC Biologics Business Overview
7.6.3 AGC Biologics Plasmid DNA Manufacturing Services Major Product Offerings
7.6.4 AGC Biologics Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.6.5 AGC Biologics Key News
7.7 Andelyn Biosciences
7.7.1 Andelyn Biosciences Corporate Summary
7.7.2 Andelyn Biosciences Business Overview
7.7.3 Andelyn Biosciences Plasmid DNA Manufacturing Services Major Product Offerings
7.7.4 Andelyn Biosciences Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.7.5 Andelyn Biosciences Key News
7.8 Biomay
7.8.1 Biomay Corporate Summary
7.8.2 Biomay Business Overview
7.8.3 Biomay Plasmid DNA Manufacturing Services Major Product Offerings
7.8.4 Biomay Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.8.5 Biomay Key News
7.9 VGXI, Inc.
7.9.1 VGXI, Inc. Corporate Summary
7.9.2 VGXI, Inc. Business Overview
7.9.3 VGXI, Inc. Plasmid DNA Manufacturing Services Major Product Offerings
7.9.4 VGXI, Inc. Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.9.5 VGXI, Inc. Key News
7.10 VectorBuilder
7.10.1 VectorBuilder Corporate Summary
7.10.2 VectorBuilder Business Overview
7.10.3 VectorBuilder Plasmid DNA Manufacturing Services Major Product Offerings
7.10.4 VectorBuilder Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.10.5 VectorBuilder Key News
7.11 Xpress Biologics
7.11.1 Xpress Biologics Corporate Summary
7.11.2 Xpress Biologics Business Overview
7.11.3 Xpress Biologics Plasmid DNA Manufacturing Services Major Product Offerings
7.11.4 Xpress Biologics Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.11.5 Xpress Biologics Key News
7.12 Biovian
7.12.1 Biovian Corporate Summary
7.12.2 Biovian Business Overview
7.12.3 Biovian Plasmid DNA Manufacturing Services Major Product Offerings
7.12.4 Biovian Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.12.5 Biovian Key News
7.13 WuXi Advanced Therapies
7.13.1 WuXi Advanced Therapies Corporate Summary
7.13.2 WuXi Advanced Therapies Business Overview
7.13.3 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Major Product Offerings
7.13.4 WuXi Advanced Therapies Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.13.5 WuXi Advanced Therapies Key News
7.14 Catalent, Inc
7.14.1 Catalent, Inc Corporate Summary
7.14.2 Catalent, Inc Business Overview
7.14.3 Catalent, Inc Plasmid DNA Manufacturing Services Major Product Offerings
7.14.4 Catalent, Inc Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.14.5 Catalent, Inc Key News
7.15 Charles River Laboratories
7.15.1 Charles River Laboratories Corporate Summary
7.15.2 Charles River Laboratories Business Overview
7.15.3 Charles River Laboratories Plasmid DNA Manufacturing Services Major Product Offerings
7.15.4 Charles River Laboratories Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.15.5 Charles River Laboratories Key News
7.16 Esco Aster Pte. Ltd
7.16.1 Esco Aster Pte. Ltd Corporate Summary
7.16.2 Esco Aster Pte. Ltd Business Overview
7.16.3 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Major Product Offerings
7.16.4 Esco Aster Pte. Ltd Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.16.5 Esco Aster Pte. Ltd Key News
7.17 Waisman
7.17.1 Waisman Corporate Summary
7.17.2 Waisman Business Overview
7.17.3 Waisman Plasmid DNA Manufacturing Services Major Product Offerings
7.17.4 Waisman Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.17.5 Waisman Key News
7.18 Boehringer Ingelheim Biopharmaceuticals GmbH
7.18.1 Boehringer Ingelheim Biopharmaceuticals GmbH Corporate Summary
7.18.2 Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview
7.18.3 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Major Product Offerings
7.18.4 Boehringer Ingelheim Biopharmaceuticals GmbH Plasmid DNA Manufacturing Services Revenue in Global Market (2017-2022)
7.18.5 Boehringer Ingelheim Biopharmaceuticals GmbH Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
